Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →
SYRE · $15K+ · 53 trades
Trades
53
Buys 0 · Sells 53
People
10
Stocks
1
Disclosed value
$1.6B
range midpoints · Congress & executive
Filed late
0
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$241Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$1.5Mdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$285Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$368Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$660Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$243Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$35.7Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$242Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$1.6Mdisclosed Oct 2 · filed 2 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$135Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$53.5Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$466Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$53.4Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$193Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$21.4Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$195Kdisclosed Oct 2 · filed 1 day after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$419Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$547Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$17.8Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$35.8Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$177Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$382Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$1.6Mdisclosed Sep 3 · filed 1 day after the trade
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$36Kdisclosed Sep 3 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$77.6Kdisclosed Sep 3 · filed 2 days after the trade